MUC1 and MUC4 are reported to be involved in stemness which confers drug resistance in cancer cells, implicating that overexpression of IL-17RB may lead to enhancement of chemotherapy resistance through upregulation of these genes in pancreatic cancer cells. Here, MUC1 is linked to pancreatic neoplasm.